TRAVERE THERAPEUTICS INC's ticker is and the CUSIP is 89422GAA5.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,373,729 | -20.4% | 45,400,000 | 0.0% | 0.33% | -24.7% |
| Q2 2023 | $36,908,513 | -1.1% | 45,400,000 | +19.8% | 0.44% | -0.7% |
| Q1 2023 | $37,317,810 | +8.0% | 37,900,000 | 0.0% | 0.44% | +23.2% |
| Q4 2022 | $34,560,605 | -10.7% | 37,900,000 | 0.0% | 0.36% | -14.1% |
| Q3 2022 | $38,693,000 | +3.8% | 37,900,000 | +2.4% | 0.42% | +11.8% |
| Q2 2022 | $37,277,000 | +2.8% | 37,000,000 | +8.8% | 0.37% | +5.4% |
| Q1 2022 | $36,271,000 | – | 34,000,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 18,167 | $17,858 | 1.50% |
| BRAIDWELL LP | 28,350,000 | $27,868,050 | 0.92% |
| READYSTATE ASSET MANAGEMENT LP | 9,000,000 | $8,847,000 | 0.82% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 21,382,000 | $20,985 | 0.77% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 20,000,000 | $19,700,500 | 0.60% |
| CSS LLC/IL | 8,178,000 | $8,038,680 | 0.53% |
| WOLVERINE ASSET MANAGEMENT LLC | 37,900,000 | $37,317,810 | 0.44% |
| Segantii Capital Management Ltd | 10,000,000 | $9,827,050 | 0.34% |
| LINDEN ADVISORS LP | 28,993,000 | $28,511,354 | 0.30% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 30,893,000 | $30,367,819 | 0.15% |